No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Household & Personal Products
Yunnan Botanee Bio-Technology Group Co.LTD operates within the Chinese market, specializing in the development and distribution of a broad spectrum of skincare formulations. Its comprehensive product line encompasses cleansing and makeup removal solutions, facial masks, toners, serums, hydrating moisturizers, eye creams, refreshing facial sprays, sun protection items, cosmetic foundations, and general body care products. This enterprise, founded in 2010, is strategically headquartered in Kunming, China.
www.botanee.com.cnNo one on the platform currently holds 300957.SZ.
No tracked institution reports a position in 300957.SZ as of their last filing.
No one on the platform has traded 300957.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.8% | 21.2% | — | — | — | |
| Rev. Growth % | -6.6% | 15.2% | ||||
| Profit Margin % | 9.4% | 14.8% | ||||
| Free Cash Flow Margin % | 9.2% | 10.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.9B | +7.4% | $1.48 | $1.33–$1.58 | — | 6 |
| 2027 | $6.5B | +9.7% | $1.71 | $1.51–$1.86 | — | 7 |
| 2028 | $7.1B | +8.1% | $1.93 | $1.49–$2.24 | — | 9 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-24 | $0.63 | $0.53 | -17.2% |
| 2026-04-26 | $0.46 | $0.55 | +19.8% |
| 2026-04-26 | $0.16 | $0.16 | +1.3% |
| 2025-10-27 | $0.33 | $0.06 | -81.7% |
| 2025-08-27 | $0.48 | $0.52 | +8.0% |
| 2025-04-25 | $0.69 | $0.21 | -69.5% |
| 2025-04-24 | $0.41 | $0.07 | -82.9% |
| 2024-10-24 | $0.29 | $-0.17 | -158.6% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300957.SZYunnan Botanee Bio-Technology Group Co.LTD | $31.44 | -0.41% | $13.2B | — |
| 002432.SZAndon Health Co., Ltd. | $60.41 | +0.95% | $28.1B | — |
| 002755.SZBeijing Aosaikang Pharmaceutical Co., Ltd. | $11.31 | -0.09% | $10.5B | — |
| 300009.SZAnhui Anke Biotechnology (Group) Co., Ltd. | $8.06 | +0.50% | $13.5B | — |
| 300049.SZInner Mongolia Furui Medical Science Co., Ltd. |
| $47.57 |
| -0.50% |
| $12.6B |
| — |
| 300204.SZStaidson (Beijing) BioPharmaceuticals Co., Ltd. | $19.65 | +1.13% | $8.9B | — |
| 300357.SZZhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | $19.17 | +0.79% | $10.0B | — |
Source: Financial Modeling Prep · peers by sector/industry